Latest Windhover Information Inc. Stories
LILLE, France and CAMBRIDGE, Mass., Oct.
EVANSTON, Ill., Aug.
SEATTLE, Nov. 16 /PRNewswire-FirstCall/ - Oncothyreon Inc.
HAYWARD, Calif., Nov.
BRISBANE, Calif., Oct.
Cortria Corporation, a clinical-stage pharmaceutical company focused on developing safe and well-tolerated medicines to fight cardiovascular disease, today announced that TRIA-662 has been selected as one of the Top 10 most promising cardiovascular projects in development.
SOUTH SAN FRANCISCO, Calif., Oct. 21 /PRNewswire-FirstCall/ -- Poniard Pharmaceuticals, Inc. , a biopharmaceutical company focused on oncology, today announced that its lead product candidate, picoplatin, has been selected by an independent committee assembled by Windhover Information Inc.
HUNTSVILLE, Ala., Sept. 5 /PRNewswire/ -- Expression Genetics, Inc. (EGEN) announced today that the company's novel TheraPlas(R) cancer drug has been selected as one of the Top 10 most promising oncology products in development available for strategic partnering.
WALTHAM, Mass., Sept. 4, 2008 (GLOBE NEWSWIRE) -- OXiGENE, Inc.
- The deadly nightshade, Atropa Belladonna, which possesses stupefying or poisonous properties.
- A sleeping-potion; a soporific.
- To mutter deliriously.